Smoking induces overexpression of immediate early genes in active graves' ophthalmopathy

Thyroid

Volumn 24, Issue 10, 2014, Pages

  Planck, Tereza ^a,b   Shahida, Bushra ^b   Parikh, Hemang ^c   Ström, Kristoffer ^b,d   Asman, Peter ^a,b   Brorson, Håkan ^a,b   Hallengren, Bengt ^a,b   Lantz, Mikael ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c YouGenomics LLC   (United States)

^d MID SWEDEN UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; HLA DRB1 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; GENETIC MARKER; IL1B PROTEIN, HUMAN; IL6 PROTEIN, HUMAN;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOCRINE OPHTHALMOPATHY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMEDIATE EARLY GENE; INTRAORBITAL FAT; MALE; REAL TIME POLYMERASE CHAIN REACTION; REFERENCE VALUE; SMOKING; SUBCUTANEOUS FAT; TISSUE MICROARRAY; UPREGULATION; ADVERSE EFFECTS; CASE CONTROL STUDY; CHEMISTRY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETIC MARKER; GENETICS; GRAVES OPHTHALMOPATHY; MIDDLE AGED; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENES, IMMEDIATE-EARLY; GENETIC MARKERS; GRAVES OPHTHALMOPATHY; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; UP-REGULATION;

EID: 84907438895     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2014.0153     Document Type: Article

References (40)

1. Bahn RS, Dutton CM, Natt N, Joba W, Spitzweg C, Heufelder AE 1998 Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy. J Clin Endocrinol Metab 83:998-1002.
2. Smith TJ 2003 The putative role of fibroblasts in the pathogenesis of Graves' disease: evidence for the involvement of the insulin-like growth factor-1 receptor in fibroblast activation. Autoimmunity 36:409-415.
3. Tomer Y 2010 Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid 20:715-725.
4. Hagg E, Asplund K 1987 Is endocrine ophthalmopathy related to smoking? Br Med J (Clin Res Ed) 295:634-635.
5. Wiersinga WM 2013 Smoking and thyroid. Clini Endocrinol 79:145-151.
6. Traisk F, Tallstedt L, Abraham-Nordling M, Andersson T, Berg G, Calissendorff J, Hallengren B, Hedner P, Lantz M, Nystrom E, Ponjavic V, Taube A, Torring O, Wallin G, Asman P, Lundell G 2009 Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131. J Clin Endocrinol Metab 94:3700-3707.
7. Tallstedt L, Lundell G, Blomgren H, Bring J 1994 Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? Eur J Endocrinol 130:494-497.
8. Tallstedt L, Lundell G, Torring O, Wallin G, Ljunggren JG, Blomgren H, Taube A 1992 Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. N Engl J Med 326:1733-1738.
9. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A 1998 Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 338:73-78.
10. Starkey K, Heufelder A, Baker G, Joba W, Evans M, Davies S, Ludgate M 2003 Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use? J Clin Endocrinol Metab 88:55-59.
11. Dorkhan M, Lantz M, Frid A, Groop L, Hallengren B 2006 Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes. Clin Endocrinol (Oxf) 65:35-39.
12. Tang QQ, Otto TC, Lane MD 2003 CCAAT/enhancerbinding protein beta is required for mitotic clonal expansion during adipogenesis. Proc Natl Acad Sci U S A 100: 850-855.
13. Laudes M, Christodoulides C, Sewter C, Rochford JJ, Considine RV, Sethi JK, Vidal-Puig A, O'Rahilly S 2004 Role of the POZ zinc finger transcription factor FBI-1 in human and murine adipogenesis. J Biol Chem 279:11711-11718.
14. Rosen ED, MacDougald OA 2006 Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7:885-896.
15. Adamson DJ, Frew D, Tatoud R, Wolf CR, Palmer CN 2002 Diclofenac antagonizes peroxisome proliferator-activated receptor-gamma signaling. Mol Pharmacol 61:7-12.
16. Vondrichova T, de Capretz A, Parikh H, Frenander C, Asman P, Aberg M, Groop L, Hallengren B, Lantz M 2007 COX-2 and SCD, markers of inflammation and adipogenesis, are related to disease activity in Graves' ophthalmopathy. Thyroid 17:511-517.
17. Lantz M, Vondrichova T, Parikh H, Frenander C, Ridderstrale M, Asman P, Aberg M, Groop L, Hallengren B 2005 Overexpression of immediate early genes in active Graves' ophthalmopathy. J Clin Endocrinol Metab 90:4784-4791.
18. Planck T, Parikh H, Brorson H, Martensson T, Asman P, Groop L, Hallengren B, Lantz M Gene expression in Graves' ophthalmopathy and arm lymphedema: similarities and differences. Thyroid 21:663-674.
19. Millenaar FF, Okyere J, May ST, van Zanten M, Voesenek LA, Peeters AJ 2006 How to decide? Different methods of calculating gene expression from short oligonucleotide array data will give different results. BMC Bioinformatics 7:137.
20. Seo J, Hoffman EP 2006 Probe set algorithms: is there a rational best bet? BMC Bioinformatics 7:395.
21. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP 2003 Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31:e15.
22. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP 2003 Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
23. Zhang B, Kirov S, Snoddy J 2005 WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33:W741-748.
24. Planck T, Shahida B, Sjogren M, Groop L, Hallengren B, Lantz M 2014 Association of BTG2, CYR61, ZFP36, and SCD Gene Polymorphisms with Graves' disease and ophthalmopathy. Thyroid 24:1156-1161.
25. Almendral JM, Sommer D, Macdonald-Bravo H, Burckhardt J, Perera J, Bravo R 1988 Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol Cell Biol 8:2140-2148.
26. Inuzuka H, Nanbu-Wakao R, Masuho Y, Muramatsu M, Tojo H, Wakao H 1999 Differential regulation of immediate early gene expression in preadipocyte cells through multiple signaling pathways. Biochem Biophys Res Commun 265:664-668.
27. Cawood TJ, Moriarty P, O'Farrelly C, O'Shea D 2007 Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link. J Clin Endocrinol Metab 92:59-64.
28. Chen CC, Mo FE, Lau LF 2001 The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J Biol Chem 276:47329-47337.
29. Sempowski GD, Rozenblit J, Smith TJ, Phipps RP 1998 Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production. Am J Physiol 274:C707-714.
30. Kim JN, Kim HJ, Jeong SH, Kye YC, Son SW 2011 Cigarette smoke-induced early growth response-1 regulates the expression of the cysteine-rich 61 in human skin dermal fibroblasts. Exp Dermatol 20:992-997.
31. Kireeva ML, Mo FE, Yang GP, Lau LF 1996 Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol 16:1326-1334.
32. Yeger H, Perbal B 2007 The CCN family of genes: a perspective on CCN biology and therapeutic potential. J Cell Commun Signal 1:159-164.
33. Haas CS, Creighton CJ, Pi X, Maine I, Koch AE, Haines GK, Ling S, Chinnaiyan AM, Holoshitz J 2006 Identification of genes modulated in rheumatoid arthritis using complementary DNA microarray analysis of lymphoblastoid B cell lines from disease-discordant monozygotic twins. Arthritis Rheum 54:2047-2060.
34. Zhang Q, Wu J, Cao Q, Xiao L, Wang L, He D, Ouyang G, Lin J, Shen B, Shi Y, Zhang Y, Li D, Li N 2009 A critical role of Cyr61 in interleukin-17-dependent proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum 60:3602-3612.
35. Kok SH, Hou KL, Hong CY, Wang JS, Liang PC, Chang CC, Hsiao M, Yang H, Lai EH, Lin SK 2011 Simvastatin inhibits cytokine-stimulated Cyr61 expression in osteoblastic cells: a therapeutic benefit for arthritis. Arthritis Rheum 63:1010-1020.
36. Ban Y, Davies TF, Greenberg DA, Concepcion ES, Osman R, Oashi T, Tomer Y 2004 Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun 5:203-208.
37. Simmonds MJ, Howson JM, Heward JM, Cordell HJ, Foxall H, Carr-Smith J, Gibson SM, Walker N, Tomer Y, Franklyn JA, Todd JA, Gough SC 2005 Regression mapping of association between the human leukocyte antigen region and Graves disease. Am J Hum Genet 76:157-163.
38. Lundstrom E, Kallberg H, Alfredsson L, Klareskog L, Padyukov L 2009 Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important. Arthritis Rheum 60: 1597-1603.
39. Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A, Pedersen BV, Wohlfahrt J, Frisch M 2007 Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark. Arthritis Rheum 56:1446-1453.
40. Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, Ronnelid J, Harris HE, Ulfgren AK, Rantapaa-Dahlqvist S, Eklund A, Padyukov L, Alfredsson L 2006 A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54:38-46.